Description
GSK-690693 is an inhibitor of Akt that displays anticancer chemotherapeutic activity. In lung and colon cancer cells, GSK-690693 inhibits cell growth. In animal models of osteosarcoma, this compound increases survival rates and decreases tumor growth. In other transgenic animal models, GSK-690693 delays lung tumor formation, decreases cell proliferation, and induces apoptosis.